Misplaced Pages

Accuray

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
American radiation therapy company

Accuray
Company typePublic company
Traded asNasdaq: ARAY
Founded1992
FounderJohn R. Adler
HeadquartersMadison, Wisconsin, United States
ProductsCyberKnife, tomotherapy

Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It is the developer of innovative technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, the latest generation TomoTherapy platform. The company is headquartered in Sunnyvale, CA, the United States. The platforms are installed in leading healthcare centres in approximately 50 countries globally.

History

Accuray was founded in 1990 by John R. Adler, a Stanford neurosurgeon, and commenced commercial operations in 1992.

In February 2007, Accuray was registered under the ticker NASDAQ:ARAY. In 2011, Accuray completed its $277 million acquisition of TomoTherapy Inc., creator of advanced radiation therapy solutions for cancer care.

In 2012, the company acquired Morphormics for a total $5.7 million. Morphormics was founded by University of North Carolina at Chapel Hill faculty and specialized in developing imaging software.

In 2015, Accuray signed an agreement with RaySearch Laboratories AB to integrate treatment planning support for TomoTherapy, Radixact and CyberKnife.

In July 2019, Accuray joint venture with CNNC Accuray in Tianjin received the license for operating in China.

In August 2023, Accuray changed its head quarters from Sunnyvale, California USA to Madison, Wisconsin, USA.

Partners

References

  1. "Accuray Is A Promising Radiation Oncology Buy In 2018 (NASDAQ:ARAY) | Seeking Alpha". seekingalpha.com. November 16, 2018. Retrieved January 9, 2023.
  2. "Accuray Incorporated : Annual Report for Fiscal Year Ending --06-30, 2022 (Form 10-K)". August 17, 2022.
  3. Saul, Stephanie (December 17, 2008). "Geography Has Role in Medicare Cancer Coverage". The New York Times. ISSN 0362-4331. Retrieved January 9, 2023.
  4. Development, PodBean. "John Adler: How to Handle Money and Investors | The Health Technology Podcast". rosenman.podbean.com. Retrieved January 9, 2023.
  5. Ward's Business Directory of U.S. Private and Public Companies. Gale Research. 1998. ISBN 978-1-4144-0017-4.
  6. "Accuray IPO raises $288 mln, top of range". Reuters. February 8, 2007. Retrieved January 9, 2023.
  7. Feder, Barnaby J. (February 12, 2008). "A Medical Robot Makes Headway". The New York Times. ISSN 0362-4331. Retrieved January 9, 2023.
  8. "Accuray to buy TomoTherapy for about $277 million". Reuters. March 7, 2011. Retrieved January 9, 2023.
  9. "Accuray to Acquire Morphormics, Inc". Fierce Healthcare. July 19, 2012. Retrieved January 9, 2023.
  10. Garde, Damian (July 17, 2012). "Accuray buys Morphormics for $5.7M". Fierce Biotech. Retrieved January 9, 2023.
  11. "Accuray Extends Ties with RaySearch Laboratories, Stock Up". Nasdaq. October 6, 2015.
  12. "CNNC Accuray Medical Technology receives safety license in China. – Free Online Library". www.thefreelibrary.com. Retrieved January 9, 2023.
  13. Crotti, Nancy (January 28, 2019). "Accuray partners with Chinese company to sell in China". Medical Design and Outsourcing. Retrieved January 9, 2023.
  14. FuturesMarketResearch (February 28, 2019). "Oncology Information System Market – Deep Research Analysis Report on Latest and Future Insights |". Medgadget. Retrieved January 9, 2023.
  15. "Transforming healthcare with software-based technology". Brainlab. Retrieved January 22, 2024.
  16. "GE HealthCare". www.gehealthcare.com. Retrieved January 22, 2024.
  17. "Software in radiation therapy and oncology". RaySearch Laboratories. Retrieved January 22, 2024.
  18. "Delta4 Family". Delta4 Family. Retrieved January 22, 2024.
Categories: